Abstract:BACKGROUND: Poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-glutamic acid) (PEG-PLA-PGL) tri-block copolymers have good applied foreground in constructing tissue engineering scaffold materials. Whether endothelial cells survive and grow on the materials has a direct influence on the application as a biodegradable material for the scaffold of endothelial cell vector.OBJECTIVE: To explore the cytocompatibility of PEG-PLA-PGL tri-block copolymers with human umbilical vein endothelial cells (HUVECs).DESIGN: Randomized control observation.SETTING: the Second Hospital of Jilin University.MATERIALS: The experiment was carried out in the Department of Pathobiology, School of Basic Medical Sciences, Jilin University from February to October in 2006. Human umbilical cord about 20 cm length came from one neonatal infant who was delivered normally after enough months in the Department of Gynecology and Obstetrics, the Second Hospital of Jilin University. Human umbilical cord was sampled in the informed consents of the infant's family member. The experimentation was authorized by the medical ethic committee of the hospital. PEG-PLA-PGL membranes were provided by Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. Inverted microscope and phase-contrast microscope were bought from Olympus Company (Japan).METHODS: HUVECs cultivated and grew steadily, were inoculated onto PEG-PLA-PGL membranes, serving as the experiment group. While the culture medium without PEG-PLA-PGL membranes were taken as the control group.①Cytocompatibility of PEG-PLA-PGL membranes with HUVECs was evaluated by observing cellular growth through phase-contrast microscope.②The proliferation index of cells was detected by MTT method in 1, 3, 5 and 7 days after inoculation.MAIN OUTCOME MEASURES: ①Cytocompatibility of PEG-PLA-PGL membranes with HUVECs;②The proliferation index of cells in l, 3, 5 and 7 days after inoculationRESULTS: ①Cytocompatibility of PEG-PLA-PGL membranes with HUVECs: The observation result of phase contrast microscopy showed that, endothelial cells planted on the PEG-PLA-PGL membranes began to attach and stretch after being planted 4-6 hours. Three days later, cells grew in colonies rapidly, after 5 days, colonies began to fuse and seemed like cobble-stone. The cells were shuttle or polygon in shape after passages. There were no significant differences between the experiment and control group. Cells cultured on PEG-PLA-PGL membranes for 15 days grew in inserts with membranes, but they didn't grow into patches through scanning electron microscope.②The proliferation index of cells: No significant differences of the proliferation index of cells were detected by MTT method in 1, 3, 5 and 7 days after inoculation between experiment group and control group (P＞0.05).CONCLUSION: Endothelial cells grow well in PEG-PLA-PGL membranes, and the two have good cytocompatibility.

Cytocompatibility of Biodegradable PEG-PLA-PGL/RGD with Human Umbiliacal Vein Endothelial Cells Cultivated in Vitro

Cytocompatibility of Biodegradable Poly(ethylene Glycol)-B-poly(l-lactide)-b-poly(l-glutamic Acid) Tri-Block Copolymer with Human Umbilical Vein Endothelial Cells

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Fabrication of PEGylated decellularized valves modified byoisteoprotegerin in vitro and their influences on human umbilical vein endothelial cells proliferation and migration

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Compatibility of human umbilical vein endothelial cells and surface-modified PHBHHx film in vitro

In Vivo Study of Biocompatibility of PEG-PLA-PGL As Biodegradable Carrier of Drug Eluting Stent

Co-electrospun Blends of PU and PEG As Potential Biocompatible Scaffolds for Small-Diameter Vascular Tissue Engineering

Promoting endothelialization on decellularized porcine aortic valve by immobilizing branched polyethylene glycolmodified with cyclic-RGD peptide: an in vitro study.

Sphingosine 1‐phosphate Potentiated Endothelial Cell Attachment on De‐cellularized Human Umbilical Vein as a Scaffold for Vascular Tissue Engineering

In vitro biocompatibility evaluation of silk-fibroin/polyurethane membrane with cultivation of HUVECs

Novel Human Endothelial Cell-Engineered Polyurethane Biomaterials for Cardiovascular Biomedical Applications.

Fabrication of PU/PEGMA Crosslinked Hybrid Scaffolds by in Situ UV Photopolymerization Favoring Human Endothelial Cells Growth for Vascular Tissue Engineering.

Poly(ethylene glycol) Hydrogels with the Sustained Release of Hepatocyte Growth Factor for Enhancing Vascular Regeneration.

Evaluation of decellularized human umbilical vein (HUV) for vascular tissue engineering – comparison with endothelium‐denuded HUV

Biofunctionalized Electrospun PCL-PIBMD/SF Vascular Grafts with PEG and Cell-Adhesive Peptides for Endothelialization

Effects of S1P on endothelial cell reattachment on de‐cellularized HUV scaffold for vascular tissue engineering (867.13)

Plga/Sf Blend Scaffolds Modified with Plasmid Complexes for Enhancing Proliferation of Endothelial Cells

In Vitro Evaluation of Biocompatibility and Surface Modification of 3 Kinds of Artificial Graft Material

Polyethylene glycol crosslinked decellularized single liver lobe scaffolds with vascular endothelial growth factor promotes angiogenesis in vivo

Establishment of PEGylated decellularized valves modified by vascular endothelial growth factor in vitro